companydata.dkcompanydata.dk

Mundipharma A/S: Financial statements 2018

CVR: 17981994

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

Mundipharma A/S (CVR 17981994) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 55,436,000 and a net result of DKK -152,000 compared with DKK -8,267,000 the year before. That is a decrease of 12.4% compared with the year before. The profit margin was -0.3%. Equity in the 2018 report amounted to DKK 47,287,000. The solvency ratio was 34.6%. The company had 26 employees in the financial year.

Revenue
DKK 55,436,000
Gross Profit
DKK 24,872,000
Profit/Loss
DKK -152,000
Equity
DKK 47,287,000
Total Assets
DKK 136,685,000
Employees
26

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201855.4M24.9M-152K47.3M26
201763.3M25.4M-8.3M47.4M23
201673M24.2M2.4M55.7M41
20152.8B-51.5M128.3M39
20142.4B77.5M33.8M76.8M44

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Mundipharma A/S: The 2017 annual report is outJun 13, 2018

Mundipharma A/S has published its annual report for 2017. Revenue came to DKK 63,266,000, and the net result was DKK -8,267,000.

Stuart David Baker joins the board of Mundipharma A/SApr 1, 2018

As of April 1, 2018, Stuart David Baker has joined the board of directors of Mundipharma A/S.

Åke Gunnar Wikström joins the board of Mundipharma A/SApr 1, 2018

As of April 1, 2018, Åke Gunnar Wikström has joined the board of directors of Mundipharma A/S.

Christopher Benbow Mitchell leaves the board of Mundipharma A/SApr 1, 2018

As of April 1, 2018, Christopher Benbow Mitchell has left the board of directors of Mundipharma A/S.

Stuart David Baker leaves the board of Mundipharma A/SMar 31, 2018

As of March 31, 2018, Stuart David Baker has left the board of directors of Mundipharma A/S.

Kjetil Kollstad joins Mundipharma A/S as adm. dir.Feb 1, 2018

As of February 1, 2018, Kjetil Kollstad is registered as adm. dir. of Mundipharma A/S.

Anders With Fogstrup steps down as director of Mundipharma A/SFeb 1, 2018

As of February 1, 2018, Anders With Fogstrup has stepped down as director of Mundipharma A/S.

About Mundipharma A/S

Mundipharma A/S is a Danish company of the type Aktieselskab based in Vedbæk, founded in 1994. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Norpharma A/S and NORPHARMA A/S. The management consists of Lisbeth Kattenhøj. The board consists of Stephen Johan Jamieson (chair), Bryan George Lea and Lisbeth Kattenhøj. The company is owned by Halm S.à.r.l., RSS Captain Trust Holdings LLC and JDS Captain Trust Holdings LLC. The company has 3 employees (2026). In 2025, the company reported revenue of DKK 25,912,000 and a net result of DKK 672,000 compared with DKK 514,000 the year before. Equity in the 2025 report amounted to DKK 38,165,000.

Source: annual report 2025, Danish Business Authority